Free Webinar: Dermatological Care in a time of COVID-19
Join Aimed Alliance for a FREE webinar on May 21, 2020 at 3:00pm ET. Are you interested in the implications…
Browsing: Resources
Aimed Alliance Leads Efforts to Ask CMS to Improve Access to Treatment for High Risk Medicare Beneficiaries
On April 23, 2020, Aimed Alliance submitted sign-on letters to the Centers for Medicare and Medicaid Services (CMS) to request…
Free Webinar: CBD in the Workplace: What Employers Need to Know
Join Aimed Alliance for a FREE webinar on May 28, 2020 from 3:00pm to 4:00 pm ET. This webinar will…
Aimed Alliance and the Alliance for Balanced Pain Management Release Know Your Rights Brochure for Patients with Arthritis
On March 25, 2020, Aimed Alliance and the Alliance for Balanced Pain Management (AfBPM) jointly released a new Know Your…
Aimed Alliance Sends Letter in Support of Tennessee Bill to Limit White Bagging and Brown Bagging
On April 14, 2020, Aimed Alliance sent a letter to members of Tennessee’s Senate Committee on Commerce and Labor in…
Aimed Alliance Releases Fact Sheet on Expanded Home Health Services for Medicare Beneficiaries
Today, Aimed Alliance released a fact sheet entitled “Expansion of Home Health Services for Medicare Beneficiaries.” The fact sheet summarizes…
Aimed Alliance Submits Comments to FDA / FTC on Competitive Marketplace for Biosimilars
On March 9, 2020, the U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) held a workshop…
Aimed Alliance Leads Sign-on Letter Calling on States to Improve Access to Care in Response to COVID-19 Outbreak
On March 31, 2020, Aimed Alliance led an effort to encourage state governors and Medicaid directors to rapidly respond to…
Free Webinar: Providing Quality Benefits for Employees with Inflammatory Bowel Disease and Other Chronic Conditions
Join Aimed Alliance for a FREE webinar on May 6, 2020 from 1:00pm to 2:00 pm ET. This webinar will…
Aimed Alliance Releases Position Statement on Cannabidiol (CBD)
On March 30, 2020, Aimed Alliance published a position statement on products containing cannabidiol (CBD). This policy document describes how…